These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2666975)

  • 21. Alternative complement pathway in bovine serum: lysis of human erythrocytes.
    Pang AS; Aston WP
    Am J Vet Res; 1977 Mar; 38(3):355-9. PubMed ID: 403835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of in vitro inhibition of activation of the classical and alternative pathways of human complement by the magnesium and sodium salts of the anti-inflammatory peptide N-acetyl-aspartyl-glutamic acid (NAAGA).
    Feuillard J; Maillet F; Goldschmidt P; Weiss L; Kazatchkine MD
    Agents Actions; 1991 Mar; 32(3-4):343-6. PubMed ID: 1862751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on activation and levels of haemolytic complement of buffalo (Bubalus bubalis). II. Alternate complement pathway activity in serum.
    Arya A; Goel MC
    Vet Immunol Immunopathol; 1992 Jan; 30(4):411-8. PubMed ID: 1546445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the haemolytic complement of the dromedary camel (Camelus dromedarius). II. Alternate complement pathway haemolytic activity in serum.
    Olaho-Mukani W; Nyang'ao JN; Kimani JK; Omuse JK
    Vet Immunol Immunopathol; 1995 Sep; 48(1-2):169-76. PubMed ID: 8533311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mathematical studies of complement activation.
    Garrigue MA; Muh JP; Bardos P
    Clin Chim Acta; 1983 Aug; 132(2):117-25. PubMed ID: 6616867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of various treatments of bovine complement on its lytic efficacy measured by two different tests.
    Nielsen K; Rosenbaum B; Ballinger R; Stiller J
    Vet Immunol Immunopathol; 1984 Jul; 6(3-4):273-83. PubMed ID: 6385462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the alternative and classical complement pathways by Entamoeba histolytica.
    Calderon J; Schreiber RD
    Infect Immun; 1985 Nov; 50(2):560-5. PubMed ID: 2865212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemolysis of human erythrocytes heavily sensitized with sheep amboceptor by sheep complement chelated with EGTA or Mg2+-EGTA.
    Stankiewicz M; Jonas W
    Vet Immunol Immunopathol; 1981 Jun; 2(3):253-64. PubMed ID: 6178207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic inhibition of the early phase of complement activation.
    Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
    Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA).
    Etievant M; Leluc B; David B
    Agents Actions; 1988 Jun; 24(1-2):137-44. PubMed ID: 3261498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel.
    Truedsson L; Sjöholm AG; Laurell AB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):161-6. PubMed ID: 7032205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement-inhibiting and anti-inflammatory properties of chlorazole fast pink 2BL.
    Doherty NS
    Clin Exp Immunol; 1981 Feb; 43(2):260-9. PubMed ID: 7273480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer.
    Webster GF; McArthur WP
    Int Arch Allergy Appl Immunol; 1981; 66(3):304-9. PubMed ID: 6913544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro inhibition of the classical pathway of human complement by polymyxin B.
    Asghar SS; Boot T; van der Helm HJ
    Biochem Pharmacol; 1987 Sep; 36(18):2927-30. PubMed ID: 2820426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function.
    Fine DP
    Infect Immun; 1977 Apr; 16(1):124-8. PubMed ID: 406201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of complement by a series of substituted 2-aryl-1,3-indandiones: interaction with the fifth component of complement.
    Asghar SS; Siddiqui AH; van der Goot H; Timmerman H
    Mol Immunol; 1986 May; 23(5):459-65. PubMed ID: 3748011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a streptococcal preparation on the complement system.
    Kato H; Yokoe N; Matsumura N; Nishida K; Ikezaki M; Hosokawa K; Hotta T; Takemura S; Yoshikawa T; Kondo M
    Jpn J Exp Med; 1979 Oct; 49(5):343-50. PubMed ID: 529490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the alternative complement pathway by blood culture isolates of Bacteroides fragilis.
    Joiner KA; Hawiger A; Gelfand JA
    Infect Immun; 1981 Oct; 34(1):303-5. PubMed ID: 6795126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the classical and alternative pathways of the human complement system by glycosaminoglycan polysulfate.
    de Messias IT; Mohren D; Kajdacsy-Balla A
    J Investig Allergol Clin Immunol; 1994; 4(4):172-6. PubMed ID: 7850029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.